MORGAN STANLEY - 31 Dec 2024 SCHEDULE 13G/A Report for Axogen, Inc. Common Stock (AXGN)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Symbol
AXGN
Shares outstanding
43,969,925 shares
Disclosed Ownership
2,330,406 shares
Ownership
5.3%
Form type
SCHEDULE 13G/A
Filing time
03 Feb 2025, 15:33:18 UTC
Date of event
31 Dec 2024

Sponsored

Quoteable Key Fact

"MORGAN STANLEY disclosed 5.3% ownership in Axogen, Inc. Common Stock (AXGN) on 31 Dec 2024."

Quick Takeaways

  • MORGAN STANLEY filed SCHEDULE 13G/A for Axogen, Inc. Common Stock (AXGN).
  • Disclosed ownership: 5.3%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 03 Feb 2025, 15:33.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 5.3% 2,330,406 0 2,310,019 Christopher O'Hara Authorized Signatory, Morgan Stanley
Morgan Stanley Capital Services LLC 3.6% 1,605,019 0 1,605,019 Christopher O'Hara Authorized Signatory, Morgan Stanley Capital Services LLC